ERBB2 and breast cancer: Moreover, anti-HER2 therapies have deeply changed the treatment approach and prognosis of early and advanced HER2-positive BC and the development of anti-HER2 drugs with high intracranial activity has represented one of the major improvements in the treatment of BCBM [12, 13].